Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomized placebo-controlled study in type 2 diabetes and dyslipidemic
patients.Patients will be randomized to one of four treatment arms for 16 weeks: placebo,
fenofibrate, metformin, or metformin and fenofibrate combination.